A detailed history of Jacobs Levy Equity Management, Inc transactions in Organon & Co. stock. As of the latest transaction made, Jacobs Levy Equity Management, Inc holds 1,242,135 shares of OGN stock, worth $18.3 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares
1,242,135
Previous 307,630 303.78%
Holding current value
$18.3 Million
Previous $6.37 Million 273.21%
% of portfolio
0.1%
Previous 0.03%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$18.65 - $23.03 $17.4 Million - $21.5 Million
934,505 Added 303.78%
1,242,135 $23.8 Million
Q2 2024

Aug 14, 2024

BUY
$17.45 - $21.96 $39,820 - $50,112
2,282 Added 0.75%
307,630 $6.37 Million
Q1 2024

May 15, 2024

SELL
$13.78 - $18.8 $8.24 Million - $11.2 Million
-597,679 Reduced 66.19%
305,348 $5.74 Million
Q4 2023

Feb 14, 2024

SELL
$10.95 - $17.32 $564,198 - $892,413
-51,525 Reduced 5.4%
903,027 $13 Million
Q3 2023

Nov 16, 2023

SELL
$16.59 - $23.77 $1.72 Million - $2.47 Million
-103,744 Reduced 9.8%
954,552 $16.6 Million
Q2 2023

Aug 14, 2023

BUY
$19.27 - $24.63 $6.62 Million - $8.46 Million
343,325 Added 48.02%
1,058,296 $22 Million
Q1 2023

May 15, 2023

BUY
$21.42 - $32.08 $10.9 Million - $16.4 Million
510,242 Added 249.23%
714,971 $16.8 Million
Q4 2022

Feb 14, 2023

SELL
$23.31 - $28.61 $4.02 Million - $4.93 Million
-172,433 Reduced 45.72%
204,729 $5.72 Million
Q3 2022

Nov 15, 2022

BUY
$23.4 - $34.25 $3.3 Million - $4.83 Million
141,062 Added 59.75%
377,162 $8.83 Million
Q2 2022

Aug 15, 2022

BUY
$31.66 - $38.9 $2.72 Million - $3.34 Million
85,949 Added 57.24%
236,100 $7.97 Million
Q1 2022

May 16, 2022

BUY
$30.45 - $39.36 $4.57 Million - $5.91 Million
150,151 New
150,151 $5.25 Million
Q4 2021

Feb 14, 2022

SELL
$28.67 - $37.13 $1.04 Million - $1.35 Million
-36,299 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$28.63 - $35.64 $1.04 Million - $1.29 Million
36,299 New
36,299 $1.19 Million

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $3.75B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Jacobs Levy Equity Management, Inc Portfolio

Follow Jacobs Levy Equity Management, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jacobs Levy Equity Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Jacobs Levy Equity Management, Inc with notifications on news.